切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2025, Vol. 19 ›› Issue (03) : 325 -328. doi: 10.3877/cma.j.issn.1674-3946.2025.03.025.

论著

两种不同保脾胰体尾切除术治疗胰体尾肿瘤的临床比较
李健雄1, 周江1, 李涛1, 乔培宇1, 汤鑫2,(), 董明2   
  1. 1. 719000 陕西榆林,西安交通大学第一附属医院榆林医院普通外科二病区
    2. 712000 陕西咸阳,陕西中医药大学附属医院肿瘤外科
  • 收稿日期:2024-06-04 出版日期:2025-06-26
  • 通信作者: 汤鑫
  • 基金资助:
    陕西省重点研发计划项目(2022SF-606)

Clinical comparison of two different spleen-preserving distal pancreatectomies for tumors of the body and tail of the pancreas

Jianxiong Li1, Jiang Zhou1, Tao Li1, Peiyu Qiao1, Xin Tang2,(), Ming Dong2   

  1. 1. The Second Ward of General Surgery,Yulin Hospital,The First Affiliated Hospital of Xi'an Jiaotong University,Yulin Shaaxi Province 719000,China
    2. Department of Oncology Surgery,Affiliated Hospital of Shaanxi University of Chinese Medicine,Xianyang Shaaxi Province 712000,China
  • Received:2024-06-04 Published:2025-06-26
  • Corresponding author: Xin Tang
引用本文:

李健雄, 周江, 李涛, 乔培宇, 汤鑫, 董明. 两种不同保脾胰体尾切除术治疗胰体尾肿瘤的临床比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(03): 325-328.

Jianxiong Li, Jiang Zhou, Tao Li, Peiyu Qiao, Xin Tang, Ming Dong. Clinical comparison of two different spleen-preserving distal pancreatectomies for tumors of the body and tail of the pancreas[J/OL]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2025, 19(03): 325-328.

目的

比较两种不同保脾胰体尾切除术治疗胰体尾肿瘤的疗效。

方法

回顾性分析2020年1月至2022年12月接受保脾胰体尾切除术的87例患者资料,根据术式不同分为Kimura组(n=44例)和Warshaw组(n=43例)。采用SPSS25.0软件分析数据,围手术期指标、免疫功能指标等计量资料以(±s)表示,行独立样本t检验;术后并发症发生情况、随访期间复发率、再次手术情况等计数资料行χ2检验。以P<0.05为差异有统计学意义。

结果

Kimura组患者手术时间长于Warshaw组(P<0.05),术中失血量、肛门通气时间比较,差异无统计学意义(P>0.05);Kimura组患者首次下床活动时间、引流管拔除时间、术后住院时间均短于Warshaw组(P<0.05);两组患者术后1d CD3+、CD4+、CD4+/CD8+较术前均降低,但Kimura组高于Warshaw组(P<0.05);Kimura组患者术后并发症发生率4.6%(2/44)低于Warshaw组20.9%(9/43)(P<0.05);随访期间,两组患者均未出现复发、再次手术情况。

结论

两种保脾胰体尾切除术治疗胰体尾肿瘤均可获得理想疗效,而相对于Warshaw术式,Kimura术式虽手术时间较长,但可避免术后免疫功能大幅下降,减少术后并发症发生,促进患者早期康复。

Objective

To compare the efficacy of two different spleen-preserving distal pancreatectomies in the treatment of tumors of the body and tail of the pancreas.

Methods

The data of 87 patients who underwent spleen-preserving distal pancreatectomy from January 2020 to December 2022 were retrospectively analyzed.According to different surgical methods,they were divided into the Kimura group (n=44 cases) and the Warshaw group (n=43 cases).The SPSS25.0 software was used for data analysis.Measurement data such as perioperative indicators and immune function indicators were expressed as (±s),and the independent-sample t test was performed.Count data such as the occurrence of postoperative complications,recurrence rate during follow-up,and re-operation status were analyzed by the χ2 test.A P value0.05 was considered statistically significant.

Results

The operation time of patients in the Kimura group was longer than that in the Warshaw group (P<0.05).There was no significant difference in intraoperative blood loss and the time of anal flatus between the two groups (P>0.05).The time of first getting out of bed,the time of drainage tube removal,and the postoperative hospital stay of patients in the Kimura group were all shorter than those in the Warshaw group (P<0.05).On the first day after surgery,the levels of CD3+,CD4+,and CD4+/CD8+ in both groups decreased compared with those before surgery,but the levels in the Kimura group were higher than those in the Warshaw group (P<0.05).The incidence of postoperative complications in the Kimura group was 4.6% (2/44),which was lower than 20.9% (9/43) in the Warshaw group (P<0.05).During the follow-up period,neither group had recurrence or re-operation.

Conclusion

Both spleen-preserving distal pancreatectomies can achieve ideal efficacy in the treatment of tumors of the body and tail of the pancreas.Compared with the Warshaw procedure,although the Kimura procedure has a longer operation time,it can avoid a significant decline in postoperative immune function,reduce the occurrence of postoperative complications,and promote the early recovery of patients.

表1 两组胰体尾肿瘤手术患者一般资料比较
表2 两组胰体尾肿瘤患者手术相关指标比较(±s
表3 两组胰体尾肿瘤患者术后恢复相关指标比较(±s
表4 两组胰体尾肿瘤患者术后免疫功能指标水平比较(±s
表5 两组胰体尾肿瘤患者术后并发症发生情况比较[例(%)]
[1]
齐中,张洪义.胰体尾肿瘤微创手术治疗的探索[J].中国医刊,2023,58(08): 819-821.
[2]
陈洵,董科,蒲克.腹腔镜胰体尾切除术与开腹胰体尾切除术临床效果对比研究[J/CD].中华普外科手术学杂志(电子版),2021,15(03): 271-274.
[3]
李庆,侯花屏.胰体尾局部病变患者腹腔镜保留脾脏的胰体尾切除术的可行性研究[J/CD].中华普外科手术学杂志(电子版),2020,14(02): 197-200.
[4]
Dembinski J,Cannella R,Sauvanet A,et al.Laparoscopic spleenpreserving distal pancreatectomy with splenic vessels resection(laparoscopic Warshaw procedure[)J].J Visc Surg,2022,159(5):415-423.
[5]
Granieri S,Bonomi A,Frassini S,et al.Kimura's vs Warshaw's technique for spleen preserving distal pancreatectomy: a systematic review and meta-analysis of high-quality studies[J].HPB (Oxford),2023,25(6): 614-624.
[6]
杨斌,於敏,罗建生,等.腹腔镜下保留脾脏胰体尾切除术治疗胰腺囊实性肿瘤中青年患者的临床效果(附30例报告[)J].中国内镜杂志,2023,29(01): 77-83.
[7]
Floyd T,Seok D,Jacobs M.Three-Port Laparoscopic Spleen-Preserving Distal Pancreatectomy with Splenic Vessel Preservation[J].JSLS,2022,26(2): e2021.
[8]
Maehira H,Tani M,Mori H,et al.Long-term outcomes after spleenpreserving distal pancreatectomy with splenic vessels preservation or resection: A nationwide survey of the Japanese Society of Pancreatic Surgery[J].Surgery,2024,175(6): 1570-1579.
[9]
Takagi K,Umeda Y,Yoshida R,et al.The Gastrohepatic Ligament Approach in Robotic Spleen-Preserving Distal Pancreatectomy with Resection of the Splenic Vessels: The Superior Window Approach in the Warshaw Technique[J].J Gastrointest Surg,2022,26(6): 1342-1344.
[10]
孙旭,曹国良,潘治平,等.脾血管血流控制技术在腹腔镜下Kimura法保脾胰体尾切除术中的应用[J].中华普通外科杂志,2022,37(10): 755-760.
[11]
高胜强,姜静华,罗建生.全胃悬吊联合3D腹腔镜保脾胰体尾切除术的应用价值[J].腹腔镜外科杂志,2022,27(07): 515-518.
[12]
乔家明,周振,胡皓源,等.脾神经及其免疫功能与心脑血管系统交互作用的研究进展[J].中华老年心脑血管病杂志,2024,26(02): 235-237.
[13]
Zhu A,Greene B,Tsang M,et al.Comparing the Warshaw technique with vessel-preservation in laparoscopic spleen preserving distal pancreatectomy: is there a better approach?[J].HPB (Oxford),2023,25(1): 109-115.
[14]
王健,段东峰,惠立良,等.腹腔镜与开腹Kimura法保脾远端胰腺切除术的短期疗效比较[J].腹腔镜外科杂志,2022,27(12):898-902.
[15]
Kwon YJ,Kim DY,Kim SC,et al.Comparison of splenic vessel preserving distal pancreatectomy and the Warshaw technique for solid pseudopapillary neoplasm in children[J].Pediatr Surg Int,2022,38(8): 1143-1148.
[16]
郝龙,洪晓明,沙洪存,等.腹腔镜保脾胰体尾切除术治疗体会[J].肝胆胰外科杂志,2022,34(07): 436-438.
[1] 李华志, 孙海涛, 曹广, 张雅静. 基于膜解剖的完整系膜切除+D2根治术在进展期胃癌治疗中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(03): 262-265.
[2] 李玉庆, 王刚, 李强, 李云川, 杜明新. 不同吻合术对腹腔镜远端胃癌根治术患者的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(03): 286-289.
[3] 曾繁利, 齐秩凯, 杨贺庆. 不同路径腹腔镜胆囊切除术治疗急性胆囊炎的近中期疗效比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(03): 317-320.
[4] 王占奎, 陈治远, 孙闻晖, 杨庆玲, 杨小斌. 术前免疫炎症指数及AFU水平对肝癌患者介入术后早期复发的预测研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(03): 247-250.
[5] 卢超, 陈波, 邢志祥, 周鹏, 王帅. 不同入路下腹腔镜解剖性肝脏切除术治疗肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(03): 254-257.
[6] 吉林霞, 范小春, 梁琴. 胃癌常见术后并发症类型及危险因素研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(02): 220-223.
[7] 杨培容, 潘刚, 周春霞. 胰腺癌术后胰瘘的危险因素及治疗进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(02): 228-230.
[8] 周丽君, 王露, 林巧. 腹腔镜与开腹直肠癌切除术治疗中低位直肠癌的疗效及并发症对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(02): 146-148.
[9] 陈宝鹤, 张文卓, 王隽. 头尾侧联合入路腹腔镜右半结肠癌根治术的近中期临床观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(02): 153-156.
[10] 韦洋, 赵远权, 王小波, 黄海, 陈洁. BCLC 0/A期肝细胞癌患者术后辅助治疗后早期复发风险分析及预测模型建立[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(02): 157-161.
[11] 李国防, 陈凯, 管文贤, 刘颂. 消化道术后吻合口漏小鼠动物模型的建立[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(02): 162-165.
[12] 李贞贞, 王宏刚, 崔丽丽, 缪月琴, 刘万璐. 改良管状胃—食管吻合术在腹腔镜近端胃切除消化道重建中的安全性及抗反流效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(02): 176-179.
[13] 李永红, 王骏, 肖恒军. 2025-NCCN前列腺癌诊治指南更新解读[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(02): 129-133.
[14] 赵洪洲, 魏国先, 刘龙, 杨念宾, 李丹. 腹腔镜疝修补术与传统疝修补术治疗腹股沟疝的疗效及复发率比较[J/OL]. 中华疝和腹壁外科杂志(电子版), 2025, 19(01): 79-82.
[15] 蒋佳君, 韦德令, 任洪冰, 朱海, 王继龙, 徐邦浩, 郭雅, 卢婷婷, 张灵, 吕自力, 文张. 全胰腺切除术治疗胰腺癌安全性和疗效分析并文献复习[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 281-289.
阅读次数
全文


摘要